Table 3.

Receipt of treatment of initial breast cancer diagnosis in the cohort of 934 women by breast cancer molecular subtype

Luminal A (N = 615)Luminal B (N = 42)Basal-like (N = 210)HER2-enriched (N = 67)
N (%)N (%)N (%)N (%)
Treatmenta
Surgery615 (42.4)42 (38.5)210 (44.7)67 (44.9)
Radiation252 (17.4)21 (19.3)69 (14.7)18 (12.1)
Chemotherapy231 (15.9)23 (21.1)136 (28.9)49 (32.9)
Tamoxifen352 (24.3)23 (21.1)55 (11.7)15 (10.1)
  • aColumn percentage exceed 100% due to multiple treatments.